Nexavar

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players

Motley Fool

India board rules against Bayer in cancer drug patent case

India board rules against Bayer in cancer drug patent case

Reuters

Bayer's Nexavar meets goal in thyroid cancer trial

Bayer's Nexavar meets goal in thyroid cancer trial

Reuters

Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients

Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients

Bloomberg

4SC in Talks With 3 Potential Partners for Cancer Drug

4SC in Talks With 3 Potential Partners for Cancer Drug

Bloomberg

FDA Approval and a Trial Failure: Which Is More Important?

FDA Approval and a Trial Failure: Which Is More Important?

Motley Fool

Bayer says Nexavar-Tarceva trial unsuccessful

Bayer says Nexavar-Tarceva trial unsuccessful

Reuters

Nexavar: Are 3 Failed Phase 3 Trials Enough?

Nexavar: Are 3 Failed Phase 3 Trials Enough?

Motley Fool